Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors. - Chimalakonda, Anjaneya; Burke, James; Cheng, Lihong; Catlett, Ian; Tagen, Michael; Zhao, Qihong; Patel, Aditya; Shen, Jun; Girgis, Ihab G.; Banerjee, Subhashis; Throup, John (Dermatology & Therapy, 2021)